Phase-2 human trials of Oxford’s Covid vaccine begin in Pune

Our Bureau | | Updated on: Dec 06, 2021

Phase-2 human trials of Oxford University’s Covid-19 vaccine, manufactured at Pune-based Serum Institute of India, began on Wednesday at the Bharati Vidyapeeth Medical College and Hospital in Pune.

According to the statement issued by the hospital, 350 male and female healthy volunteers (above the age of 18) will be administered this Covid-19 vaccine. Volunteers will undergo for RT-PCR and Antibody tests for Covid and only healthy volunteers will be selected as per the norms of Trial.

Bharati Hospital and Serum Institute signed the agreement to conduct the trial. “The research is being conducted with the sponsorship of the Serum Institute and is co-sponsored by Indian Council of Medical Research (ICMR). Sanjay Lalwani will be looking after the execution of trial at Bharati Hospital,” the statement added.


Read also: Two hospitals in TN to join Oxford varsity in Covishield vaccine human trials


Published on August 26, 2020
This article is closed for comments.
Please Email the Editor

You May Also Like

Recommended for you